Optune(NOVOTTF-100A)+ Bevacizumab+ Hypofractionated Stereotactic Irradiation Bevacizumab-Naive Recurrent Glioblastoma (GCC 1344)

NCT01925573 · clinicaltrials.gov ↗

NA

Phase

TERMINATED

Status

7

Enrollment

OTHER

Sponsor class

Stopped Poor accrual

Conditions

RECURRENT GLIOBLASTOMA
Brain Tumor

Interventions

DEVICE: Optune(NOVOTTF-100A)

Sponsor

University of Maryland, Baltimore

Collaborators

[object Object]